NCT06921980
Brain Function and Psychological Changes Related to Cell Therapy for Autoimmune Hemolytic Anemia
StatusRecruiting
PhaseNot specified
Primary completion (estimated)
At risk: Primary completion moved 12 months later.
See at-risk trials from Institute of Hematology & Blood Diseases Hospital, China
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 2 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Primary completion pushed from Dec 31, 2026 to Dec 31, 2027
- Eligibility criteria expanded, about 7 words
- Study completion pushed from Dec 31, 2026 to Dec 31, 2028
- Secondary endpoints: details revised at 2 of 2 entries
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Concentration changes in oxygenated hemoglobin (HbO) and de-oxygenated hemoglobin (HbR)
Timeframe: Patients will be assessed before cell therapy and on Days 1, 4, 7, 10, 14, 21, and 28 after treatment.
Psychological change
Timeframe: Patients will be assessed before cell therapy and on Days 1, 4, 7, 10, 14, 21, and 28 after treatment.
Anxiety symptoms
Timeframe: Patients will be assessed before cell therapy and on Days 1, 4, 7, 10, 14, 21, and 28 after treatment.
Depression symptoms
Timeframe: Patients will be assessed before cell therapy and on Days 1, 4, 7, 10, 14, 21, and 28 after treatment.
Secondary (2)
Sleep quality
Physical fatigue
Arms and interventions
Experimental
Brain function and psychological changes in AIHA patients will be monitored throughout cell therapy.
Other: Brain function and psychological assessment
Sites
1 site in 1 country
- Regenerative Medicine CenterTianjin, Tianjin Municipality, China